Does accounting for seizure frequency variability increase clinical trial power?

Daniel M. Goldenholz, Shira R. Goldenholz, Robert Moss, Jacqueline French, Daniel Lowenstein, Ruben Kuzniecky, Sheryl Haut, Sabrina Cristofaro, Kamil Detyniecki, John Hixson, Philippa Karoly, Mark Cook, Alex Strashny, William H. Theodore, Carl Pieper

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Does accounting for seizure frequency variability increase clinical trial power?'. Together they form a unique fingerprint.

Medicine & Life Sciences